Jeff Geschwind, MD founded Cage Pharma, focusing on innovative cancer drug development. His work targets tumor metabolism, specifically glycolysis, to create new therapeutic strategies for combating aggressive cancers. https://www.linkedin.com/in/jeff-geschwind-037200174